Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell membrane components comprise a complex assembly of lipids, proteins, and carbohydrates that define the biological boundaries and structural integrity of all living cells [2, 9]. This entry represents a broad category of molecules rather than a single specific protein or receptor, although individual constituents within the membrane serve as vital therapeutic targets [1, 4]. For instance, the fungal sterol ergosterol is a primary target for polyene and azole antifungals, which disrupt membrane integrity or inhibit synthesis to cause cell death [6, 17]. Similarly, antimicrobial lipopeptides like daptomycin and polymyxins target bacterial-specific membrane features, such as phosphatidylglycerol or lipopolysaccharides, to induce rapid depolarization [4, 6]. In oncology, the modulation of membrane-lipid composition and microdomain (lipid raft) dynamics is an emerging strategy to influence transmembrane signaling pathways and overcome drug resistance [3, 12]. Because these components are fundamental to the survival of all cells, a major challenge in drug development is achieving sufficient selectivity to avoid damaging host membranes [12, 16]. Consequently, safety concerns such as hemolysis and nephrotoxicity are frequently associated with membrane-disrupting therapeutic agents [12].
Drugs targeting cell membrane components typically act by binding to specific lipids or proteins to disrupt bilayer integrity, forming pores that lead to ion leakage and cell death, or by inhibiting the biosynthesis of critical membrane constituents like ergosterol or lipopolysaccharides.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane components.